| scholarly article | Q13442814 |
| P50 | author | Oliver Schilling | Q61159147 |
| Melanie C Föll | Q96187213 | ||
| P2093 | author name string | Martin Werner | |
| Martin L Biniossek | |||
| Vanessa Drendel | |||
| Cordula Annette Jilg | |||
| Selina Kiefer | |||
| Ann-Kathrin Müller | |||
| Bianca Heckelmann | |||
| P2860 | cites work | Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family | Q24293325 |
| STRING: a web-server to retrieve and display the repeatedly occurring neighbourhood of a gene | Q24523893 | ||
| Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis | Q26744233 | ||
| Measurement of protein using bicinchoninic acid | Q26778491 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
| Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer | Q28236013 | ||
| Prostate short-chain dehydrogenase reductase 1 (PSDR1): a new member of the short-chain steroid dehydrogenase/reductase family highly expressed in normal and neoplastic prostate epithelium | Q28631709 | ||
| MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification | Q29547200 | ||
| A model for random sampling and estimation of relative protein abundance in shotgun proteomics | Q29547316 | ||
| ProteomeXchange provides globally coordinated proteomics data submission and dissemination | Q29614806 | ||
| STRING v10: protein-protein interaction networks, integrated over the tree of life | Q29615545 | ||
| Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics | Q29615818 | ||
| limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
| Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry | Q30982577 | ||
| Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. | Q31134380 | ||
| Proteomic analysis of formalin-fixed prostate cancer tissue | Q33221442 | ||
| Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer | Q33621410 | ||
| Molecular pathways: targeting ETS gene fusions in cancer | Q34135434 | ||
| Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. | Q34157715 | ||
| Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene | Q34354479 | ||
| A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy? | Q34408322 | ||
| PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis | Q34434937 | ||
| PARP-1: a regulator of genomic stability linked with mammalian longevity | Q34596519 | ||
| Impact of routinely employed procedures for tissue processing on the proteomic analysis of formalin-fixed paraffin-embedded tissue | Q35180060 | ||
| Proteomic developments in the analysis of formalin-fixed tissue | Q35332357 | ||
| Dual roles of PARP-1 promote cancer growth and progression | Q36460391 | ||
| Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within | Q36519169 | ||
| Quality control in immunocytochemistry: experiences with the oestrogen receptor assay | Q37116000 | ||
| Transcriptional roles of PARP1 in cancer | Q38219235 | ||
| An update on PARP inhibitors--moving to the adjuvant setting | Q38257125 | ||
| Improving genome annotation of enterotoxigenic Escherichia coli TW10598 by a label-free quantitative MS/MS approach | Q38404289 | ||
| Role of PARP-1 in prostate cancer. | Q38526322 | ||
| New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy | Q38686170 | ||
| A lactate-induced response to hypoxia. | Q38884833 | ||
| The Proteome of Primary Prostate Cancer | Q38933701 | ||
| miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. | Q39513477 | ||
| A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group | Q39579259 | ||
| A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer | Q40735810 | ||
| Small organ, big reach | Q41046337 | ||
| Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. | Q41164689 | ||
| Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection | Q41235302 | ||
| Impact of cathepsin B on the interstitial fluid proteome of murine breast cancers | Q41236625 | ||
| Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC. | Q41451334 | ||
| Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer | Q43614751 | ||
| Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy | Q44749198 | ||
| The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer | Q45892459 | ||
| Human alpha beta hydrolase domain containing protein 11 and its yeast homolog are lipid hydrolases. | Q46372922 | ||
| Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer | Q49096071 | ||
| Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. | Q52936872 | ||
| [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma]. | Q53195658 | ||
| NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. | Q54509491 | ||
| Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells | Q73260063 | ||
| Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma | Q84148867 | ||
| Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer | Q85235944 | ||
| Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only | Q85822182 | ||
| P4510 | describes a project that uses | RStudio | Q4798119 |
| limma | Q112236343 | ||
| P433 | issue | 2 | |
| P921 | main subject | lymph node | Q170758 |
| P304 | page(s) | 140-151 | |
| P577 | publication date | 2017-12-14 | |
| P1433 | published in | Neoplasia | Q2962042 |
| P1476 | title | Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases | |
| P478 | volume | 20 |
| Q61799832 | ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma |
| Q89930021 | Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics |
| Q56761472 | Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance |
| Q58802544 | Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas |
| Q64117126 | Quantitative proteomic analysis of prostate tissue specimens identifies deregulated protein complexes in primary prostate cancer |
Search more.